La Jolla Labs Inc

Cenna Biosciences, LLC, based in La Jolla, California, is a biopharmaceutical company dedicated to developing innovative treatments for Alzheimer's disease. Their lead product, Nubytide, is a potential disease-modifying peptide offering a proactive therapy aimed at preventing and treating Alzheimer's, targeting inflammation and Tau pathology in the brain. With a strong intellectual property portfolio and significant market potential, Cenna aims to make Nubytide accessible to every patient suffering from Alzheimer's disease. The company has received a Phase II SBIR grant from the National Institutes of Health to support the early clinical development of Nubytide, highlighting its commitment to addressing the growing global Alzheimer's epidemic. Generated from the website

Amydis, Inc is a pioneering company based in La Jolla, CA that specializes in developing ocular tracers for the detection and monitoring of molecular biomarkers related to diseases of the eye, heart, and brain. Their cutting-edge technology enables digital detection through standard ocular imaging cameras, revolutionizing the diagnosis, clinical testing of therapeutics, and treatment of various diseases. With a focus on precision healthcare, Amydis is at the forefront of utilizing artificial intelligence to power their innovative solutions. Their groundbreaking advancements not only accelerate the diagnostic process but also have the potential to significantly improve patient outcomes. By mapping the heterogeneity of diseases like Alzheimer's, Amydis is making remarkable strides in the field of ocular biomarkers, offering eye-opening innovations that have the potential to enhance human life.Generated from the website